CP Circle ML-6 Holdco, L.P. 4

What Happened
CP Circle ML Holdco GP, LLC (a Carlyle-managed entity and reported 10% owner) sold 26,105,840 shares of Medline Class A common stock on 2026-03-10 at $41.00 per share, generating proceeds of $1,070,339,440. In a separate disposition on the same date, 2,113,483 shares were distributed (no consideration) to a limited partner. The sale is a routine institutional sale (S = sale); the distribution is reported as an "other disposition" (J) and is subject to limited partner lock-up restrictions.

Key Details

• Transaction date: 2026-03-10; sale price: $41.00; sale proceeds: $1,070,339,440.
• Sale quantity: 26,105,840 shares (detailed in footnote as transfers from multiple Carlyle-managed holdcos).
• Other disposition: 2,113,483 shares distributed pro‑rata for no consideration to a limited partner (subject to lock‑up).
• Shares held after these actions (select Carlyle entities, per filing): Carlyle Mozart Coinvestment Holdings, L.P. ~14.01M; CP Circle ML‑3 Holdco, L.P. ~50.72M (other related entities retain additional holdings).
• Notable footnotes: sale aggregated across multiple Carlyle holdcos (see F1); distribution described in F5 and F6 and limited partner is bound by a lock-up.
• Filing: Form 4 filed 2026-03-12 for 2026-03-10 transactions (appears timely — Form 4 is generally due within two business days).

Context
This was institutional selling by a Carlyle-managed group (a reported 10% owner), not an individual company executive — such disposals often reflect portfolio or liquidity actions rather than a manager-level signal about company fundamentals. The distribution to a limited partner was for no consideration and comes with contractual lock-up restrictions, which can limit immediate resale.